Table 6.
Dead patients (n = 47) according to analysed variables and OS (≤24 months; >24 months).
| Lived (Months) | ||||
|---|---|---|---|---|
| ≤24 | >24 | p * | ||
| Lymph node status; n (%) | ||||
| Negative | 28 (60%) | 16 (55%) | 12 (67%) | 0.635 |
| Positive | 19 (40%) | 13 (45%) | 6 (33%) | |
| PD-L1; n (%) | ||||
| Negative | 29 (62%) | 20 (69%) | 9 (50%) | 0.321 |
| Positive | 18 (38%) | 9 (31%) | 9 (50%) | |
| Gradus; n (%) | ||||
| 1 | 6 (13%) | 2 (7%) | 4 (22%) | 0.190 |
| 2 | 24 (32%) | 14 (50%) | 10 (56%) | |
| 3 | 16 (35%) | 12 (43%) | 4 (22%) | |
| Lympho-vascular invasion; n (%) | ||||
| No | 16 (34%) | 9 (31%) | 7 (39%) | 0.814 |
| Yes | 31 (66%) | 20 (69%) | 11 (61%) | |
| Histological type; n (%) | ||||
| ADC | 25 (56%) | 16 (57%) | 9 (53%) | 1 |
| SCC | 20 (44%) | 12 (43%) | 8 (47%) | |
| Subtype of ADC; n (%) | ||||
| Acinar | 9 (37.5%) | 5 (33.3%) | 4 (44.4%) | small sample size |
| Papillary | 6 (25%) | 4 (26.7%) | 2 (22.2%) | |
| Solid | 9 (37.5%) | 6 (40%) | 3 (33.3%) | |
* χ2 test.